Evommune Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Evommune Inc 's ROA in the second quarter of 2026?
Evommune Inc recorded a cumulative net loss of $-123 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -52.91%.

However, within the Healthcare sector Evommune Inc achieved the highest return on assets. While the total ranking for ROA unchanged, relative to the first quarter of 2026 at no. .

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	157.58 %	-	-	-	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-123	-104	-97	-57	-44
Return On Assets (TTM)	-52.91 %	-55.75 %	-91.38 %	-113.24 %	-153.07 %
EVMN's Total Ranking	#	#	#	#	#
Total Assets (TTM) in million	296	322	225	85	115
Seq. Total Assets Change	-8.07 %	43.35 %	166.07 %	-26.53 %	-
Seq. Net Income Change	-	-	-	-	-

EVMN's 5 Years Annual ROA >> Back to EVMN Management Effectiveness >> Compare EVMN ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Assets Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
Evommune Inc 's Assets	$ 296 million	EVMN's Balance sheet
Evommune Inc 's Income	$ -32 million	Quarterly EVMN's Income Statement
EVMN's Income by Division		See EVMN's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	FY	FY	FY	FY
Y / Y Total Assets Change	-	-	-	-	-
Total Assets in million	292	0	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-69	0	0	0	0
Annual Return On Assets	-23.55 %	-	-	-	-

EVMN's 5 Years Annual ROA >> Back to EVMN Management Effectiveness >> Compare EVMN ROA to its Competitors

More Return On Assets Ratios
EVMN's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
EVMN's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for EVMN's Competitors
Subscribers only: Roa for Evommune Inc 's Suppliers
Subscribers only: Return On Assets for EVMN's Customers

You may also want to know
EVMN's Roi	EVMN's Inventory Turnover Ratio	EVMN's Growth Rates	EVMN's Dividend Comparisons
	EVMN's Profitability Ratios	EVMN's Asset Turnover Ratio	EVMN's Dividend Growth
EVMN's Roe	EVMN's Valuation Ratios	EVMN's Financial Strength Ratios	EVMN's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-26T07:43:40+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.